ArticleOncoTargets and therapy2014

PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs.

Beyhan Ataseven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.